The Lancet

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

The Lancet
Nov 18, 2024, 08:15 | Blog
Vania Wisdom: Inspiring day at the Houses of Parliament during London Global Cancer Week
Vania Wisdom, Senior Executive Editor and Oncology Ambassador at The Lancet, shared a post on…
Nov 17, 2024, 23:33 | Insight
Nirmala Bhoo Pathy: Started the London Global Cancer Week at The Lancet office
Nirmala Bhoo Pathy, Professor of Epidemiology in the Department of Social and Preventive Medicine at…
Nov 17, 2024, 09:02 | Insight
Breast Cancer - Exposing hidden costs, addressing inequities
ABC Global Alliance shared an article by Prof Charlotte E Coles on LinkedIn: "When the…
Nov 15, 2024, 15:59 | Blog
Shushan Hovsepyan: Can we change the game for sarcoma patients with immunotherapy?
Shushan Hovsepyan shared on LinkedIn: "Can we change the game for sarcoma patients with immunotherapy? Two…
Nov 14, 2024, 15:58 | Insight
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 7, 2024, 14:53 | Career
Rana McKay - Candidate for ASCO Nominating Committee
Rana McKay has been nominated as the Undesignated Member Candidate of the nomination committee for…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Oct 31, 2024, 09:13 | Blog
Stella Arakelya: Benefits of Holistic Assessment-Based Interventions
Stella Arakelya, Research Fellow at Usher Institute, The University of Edinburg, shared a post by…
Oct 23, 2024, 14:03 | Blog
Gerry Hanna: Latest output from The Early Breast Cancer Trialists' Collaborative Group
Gerry Hanna, Radiation Oncologist at St James's Hospital, shared a post on X: ''Latest output from…
Oct 22, 2024, 23:21 | Blog
Isabel Mestres: Take action to address gender equity in cancer care
Isabel Mestres shared an article on LinkedIn: ''Take action to address gender equity in cancer…
Oct 22, 2024, 17:56 | Blog
Shushan Hovsepyan: Wonderful presentation by Dr. Alexandra Müller about the SAFER Ukraine
Shushan Hovsepyan posted the following on LinkedIn: “Wonderful presentation by Dr. Alexandra Müller about the…
Oct 19, 2024, 12:22 | Blog
Elisa Agostinetto: EBCTCG analysis showing a major in recurrence rates for breast cancer clinical trials between 1990-2009
Elisa Agostinetto shared a post on X: ''Out in The Lancet an EBCTCG analysis showing…
Oct 17, 2024, 18:49 | Blog
Rebecca Shatsky: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Rebecca Shatsky shared a post on X, about recent paper published in The Lancet: Reductions…
Oct 17, 2024, 18:06 | Insight
Paolo Tarantino: We cure breast cancer every day better
Paolo Tarantino shared a post on LinkedIn: "The latest EBCTCG meta-analysis of over 150.000 patients…
Oct 16, 2024, 08:04 | Insight
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Oct 15, 2024, 10:33 | Blog
Elisabetta Bonzano: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:…
Oct 15, 2024, 00:34 | Blog
Bishal Gyawali: 15 most FAQs about surrogate endpoints in oncology
Bishal Gyawali shared a post by Oncology News Central on X, adding: "My new piece in Oncology…
Oct 14, 2024, 15:14 | Drugs
Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC
Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…
Oct 13, 2024, 10:47 | Insight
Melvin L.K. Chua: The massive disparities in global radiotherapy demands
Melvin L.K. Chua shared a post on X: "This is excellent work led by Hongcheng…
Oct 12, 2024, 14:31 | Insight
Ben Ponvilawan: HCC Etiology's Impact on Positive Results in the CARES-310 Trial
Ben Ponvilawan, Doctor of Medicine at UMKC Internal Medicine Residency Program, shared on X: ''…
Oct 8, 2024, 13:52 | Insight
Strategies beyond the WHO Framework Convention on Tobacco Control could reduce deaths due to lung cancer - IARC
IARC - International Agency for Research on Cancer / WHO shared a post on LinkedIn:…
Oct 8, 2024, 12:53 | Blog
Health-care workers in fragile and conflict-ridden contexts - The Institute of Cancer and Crisis
The Institute of Cancer and Crisis shared on LinkedIn about recent paper by Patricia St…
Oct 4, 2024, 19:20 | Blog
The Lancet Oncology Commission presented at ASTRO24 - ESTRO
ESTRO shared a post on LinkedIn: ""An optimized and cost-effective radiotherapy approach could extend treatment to…
Oct 3, 2024, 17:40 | Blog
Honoring Dr Stella Arakelyan and welcoming Dr Mark Lawler as ICC's New Research Lead
The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn, adding: " On…
Sep 30, 2024, 19:23 | Insight
Erman Akkus: Microplastics in prostate tumor and para-tumor
Erman Akkus shared a post on LinkedIn: "Microplastics in prostate tumor and para-tumor 22 matched samples.…
Sep 30, 2024, 17:09 | Insight
Khalid El Bairi: Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement
Khalid El Bairi shared an article on LinkedIn: "Happy to share our second paper in…
Sep 23, 2024, 19:01 | Blog
Ophira Ginsburg: Fantastic week in Geneva with colleagues and friends from near and far
Ophira Ginsburg shared a post on X: "It’s a wrap!! Fantastic week in Geneva with colleagues…
Sep 23, 2024, 16:38 | Blog
Miriam Mutebi: Day 3 of WCC2024 focused on women, HIV and cervical cancer
Miriam Mutebi shared a post on LinkedIn: ''Day 3 of the World Cancer Congress 2024 (WCC2024).…
Sep 18, 2024, 06:20 | Blog
Toni Choueiri: Results from TiNivo2 are out at ESMO24 and The Lancet
Toni Choueiri shared a post on X: "Results from TiNivo2 are out both ESMO24 and…
Sep 17, 2024, 15:03 | Blog
Vivek Subbiah: Now that we have landed in the moon off to Mars
Vivek Subbiah shared a post on X: ''To the moon! Huge congratulations to Toni Choueiri…
Sep 17, 2024, 00:37 | Blog
Raymond Chan: Supportive cancer care 2030 ambitions published in The Lancet’s eClinicalMed
Raymond Chan, Deputy Vice-Chancellor (Research) at Flinders University, posted the following on LinkedIn: “Our The Multinational…
Sep 15, 2024, 16:26 | Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 7, 2024, 10:22 | Insight
Adding 6 months of androgen deprivation therapy to post-operative radiotherapy for prostate cancer
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn about a recent…
Sep 5, 2024, 07:07 | Insight
Saarang Deshpande on serum ferritin thresholds for iron deficiency and iron deficiency anemia
Saarang Deshpande shared on X: "As it is a global health issue reflective of health…
Aug 29, 2024, 21:18 | Blog
Miriam Mutebi: Fewer than one radiotherapy machine per million people - a heartbreaking scenario common across Africa
Miriam Mutebi shared on LinkedIn: ""It's not what I want, but let me just have a…
Aug 26, 2024, 17:19 | Blog
Improving cancer care in these challenging setting - Global Coalition for Radiotherapy
Global Coalition for Radiotherapy shared a post on LinkedIn: " RADIOTHERAPY NEWS "The first Global Summit on…
Aug 25, 2024, 09:35 | Blog
Mark Lawler protecting all cancer patients in war-torn regions
Mark Lawler shared a post by Union for International Cancer Control, on X : "On World Humanitarian…
Aug 23, 2024, 14:33 | Insight
Mark Lawler: Our Cancer in Conflict Manifesto
Mark Lawler shared on X: "Some month: Our Cancer in Conflict Manifesto in The Lancet.…
Aug 20, 2024, 14:53 | Blog
Miriam Mutebi: How we can embrace community-centered palliative care that reflects African values and realities
Miriam Mutebi shared on LinkedIn: "This weekend I spent some time thinking about how we…
Aug 19, 2024, 17:01 | Blog
Lena Mkrtchyan: Proud to be part of OncoDaily
Lena Mkrtchyan, YSMU Graduate and Content Curator at OncoDaily.com, shared a post on LinkedIn by…
Aug 19, 2024, 11:58 | Insight
Françoise Meunier on the financial discrimination faced by 20 million cancer survivors across Europe
Françoise Meunier shared a post on LinkedIn: “A new study published today in The Lancet…
Aug 18, 2024, 15:24 | Blog
Aruni Ghose: The Best Team that I’ve worked with when it comes to Cancer Reach and Coverage
Aruni Ghose shared a post on LinkedIn by Gevorg Tamamyan adding: "This is hands down…
Aug 16, 2024, 15:47 | Blog
Maite Bourlon: Leading Oncology Care with Compassion and Innovation
Maite Bourlon posted on X: "Thanks The Lancet for highlighting the work of oncology researchers…
Aug 14, 2024, 08:44 | Blog
Read an article in The Lancet on improving cancer care in conflict-impacted populations - ASCO
ASCO shared on X: "Read an article in The Lancet by our CMO Julie Gralow et…
Aug 9, 2024, 18:04 | Insight
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Meyer May-Lucie, Doctor at Gustave Roussy, shared on X about a recent paper titled "New…
Aug 7, 2024, 14:42 | Blog
Nazik Hammad: Our manifesto had a good representation from Africa but there is little focus on plight of cancer patients
Nazik Hammad shared on X: "Our manifesto published in the Lancet on August 3rd, on…
Aug 6, 2024, 11:47 | Drugs
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma
On August 2, 2024, the FDA made history by granting accelerated approval to afamitresgene autoleucel…
Aug 5, 2024, 12:59 | Blog
It's not only in Gaza and Ukraine - cancer services in long-term conflict settings - European Cancer Organisation
European Cancer Organisation shared on LinkedIn: "It's not only in Gaza or Ukraine. Today dozens…
Aug 5, 2024, 07:48 | Insight
Maria Babak: Happy to announce our second paper on recommendations to improve cancer care in regions affected by conflict
Maria Babak shared on LinkedIn: "I am happy to announce our second paper in The…
Aug 4, 2024, 12:50 | Blog
Differences in cancer rates among adults born between 1920 and 1990 in the USA
Cathy Eng posted on X about recent paper by Hyuna Sung et al., titled "Differences…
Aug 4, 2024, 11:08 | Blog
Christos Tsagkaris: The manifesto on improving cancer care in conflict-impacted populations
Christos Tsagkaris, Social Media Editor at JBI Evidence Implementation, shared a post on LinkedIn: "The…
Aug 4, 2024, 10:51 | Insight
Jemma Arakelyan: Important Manifesto after the first Global Summit on War and Cancer organized by ICC and OncoDaily
Jemma Arakelyan shared on LinkedIn: "It took us 8 months to publish this important Manifesto…
Aug 4, 2024, 06:50 | Blog
Maria Babak: The Babak Lab weekly digest highlights how developments can transform patient outcomes and broaden treatment possibilities
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by The…
Aug 2, 2024, 09:38 | OncoDaily Pulse
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Press Release First Global Summit on War and Cancer Develops Key Manifesto to Improve Cancer…
Jul 29, 2024, 10:25 | Blog
Gevorg Tamamyan: The most important thing about OncoDaily
Gevorg Tamamyan shared a post on LinkedIn: ''A few days ago, I discovered something important…
Jul 27, 2024, 13:03 | Blog
Yakup Ergün: Can we truly label a study with Grade 5 toxicity as 'acceptable' or 'manageable'?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Can we truly label…
Jul 21, 2024, 15:58 | Blog
Shushan Hovsepyan: Highlights from the ARST1431 study about treatment outcomes of RMS patients
Shushan Hovsepyan shared a post on LinkedIn: ''How can we better use molecular insights to…
Jul 21, 2024, 09:13 | Insight
Sumanta K. Pal: Excellent review on kidney cancer from Tom Powles
Sumanta K. Pal shared on X a recent paper by Matthew Young et al. titled…
Jul 19, 2024, 22:19 | Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 19, 2024, 06:53 | Blog
Part of the Lancet Discovery Science about the SIOP Europe Annual Meeting 2024 in Milan
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) shared a post on LinkedIn: "Have…
Jul 14, 2024, 07:38 | Insight
Pediatric cancers and family financial toxicity in the Philippines
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared…
Jul 12, 2024, 11:37 | Insight
More than 30 million people may be diagnosed with cancer in 2040 - The Lancet
The Lancet posted on LinkedIn: "Projections suggest more than 30 million people may be diagnosed…
Jul 12, 2024, 07:47 | Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week,  shared a posted by Parker Institute…
Jul 9, 2024, 01:25 | Blog
Annual essay competition, the Wakley Prize by The Lancet
The Lancet shared a post on LinkedIn: ''Submission alert - we’re now inviting entries to…
Jul 6, 2024, 23:07 | Blog
IARC has evaluated the carcinogenicity of talc and of acrylonitrile
IARC - International Agency for Research on Cancer shared on LinkedIn: "IARC has evaluated the…
Jul 6, 2024, 10:11 | Insight
Zainab Shinkafi-Bagudu: Great to see the team Cancer Survival Group leading a new The Lancet commission
Zainab Shinkafi-Bagudu shared a post on X: “Great to see the team Cancer Survival Group leading…
Jul 6, 2024, 09:58 | Insight
Justin Ferdinandus: BrECADD is better tolerated than eBEACOPP for patients with advanced Hodgkin Lymphoma
Justin Ferdinandus, Resident Physician at University Hospital Cologne, shared on X: “HD21 results now finally published…
Jul 5, 2024, 01:33 | Blog
Aruni Ghose: A MUST READ - penned down by Mona Hassan and Akash Maniam
Aruni Ghose shared a post by Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS…
Jun 26, 2024, 14:10 | Blog
Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma
Maria Babak shared a post by The Babak Lab on LinkedIn: “The FDA's approval of…
Jun 22, 2024, 07:03 | Blog
Zainab Shinkafi-Bagudu: Hitting article on cancer care emergency on world refugee week
Zainab Shinkafi-Bagudu shared a post by Nazik Hammad, on X: "This world refugee week, I am reminded…
Jun 19, 2024, 06:13 | Blog
Runcie Chidebe: Privileged to meet Professor Emeritus Ian F. Tannock
Runcie Chidebe shared on LinkedIn: "A few weeks ago, I was in Montreal, Canada, and…
Jun 16, 2024, 01:30 | Blog
Ophira Ginsburg: Rest in power dear Lyn…
Ophira Ginsburg shared on LinkedIn: "Rest in power dear Lyn… The Lancet Commission on women, power,…
Jun 12, 2024, 04:56 | Blog
The Rising Tide: Trends and Challenges of Lung Cancer in Asia - The Lancet
The Lancet made the following post on LinkedIn: "Join our upcoming Lancet Webinar, during which…
Jun 10, 2024, 07:25 | Blog
The phase III NETTER-2 trial published in The Lancet and presented by Pamela Kunz at ASCO24 - Yale Cancer Center
Yale Cancer Center shared a post on X: “The phase III NETTER-2 trial published in The…
Jun 7, 2024, 00:06 | Blog
Khalid El Bairi: IDEA Awardees met with one of the Lancet's editors
Khalid El Bairi shared a post on X: "It was a great pleasure for the IDEA…
Jun 4, 2024, 09:06 | Blog
Julie S. Torode: Nationwide vaccination in India with its own new CERVAVAC from Cancer World
Ophira Ginsburg shared a post by Julie S. Torode, Director of Strategic Partnerships, Patient and Community Engagement, Institute…
Jun 2, 2024, 23:26 | Blog
Runcie C.W. Chidebe: Congratulations to all the commissioners of The Lancet Commission on Women, Power and Cancer
Runcie C.W. Chidebe shared a post on X: "Understanding the intersection of gender and Cancer is…
Jun 2, 2024, 23:03 | Blog
Maite Bourlon: The Lancet Comission on women power and cancer at The ASCO Post
Maite Bourlon shared a post on X: "The Lancet Comission on women power and cancer at…
Jun 2, 2024, 22:56 | Blog
Oyepeju Abioye: Electrifying speech by Ophira Ginsburg at The Lancet Commission on Women, Power and Cancer
Ophira Ginsburg shared a post by Oyepeju Abioye, Research Assistant at Florez Lab, on X: "Thanks for your…
May 22, 2024, 04:18 | Insight
Ophira Ginsburg: Exciting upcoming events with The Lancet Commission on women, power, and cancer
Ophira Ginsburg shared a post on LinkedIn: “Check out these exciting upcoming events with The Lancet…
May 20, 2024, 14:43 | Blog
Kristina Jenei: Inspiring Lancet profiles for oncology
Kristina Jenei, Associate Editor at the Journal of Cancer Policy, shared on X/Twitter: "Love these The…
May 14, 2024, 16:52 | Insight
Fabrice Andre: This risk-based approach is the foundation of modern cancer prevention centers
Fabrice Andre, Head of Research Division at Gustave Roussy, shared on X: "In this review ⁦of…
May 14, 2024, 10:44 | Blog
Nazik Hammad: Join our session ASCO2024 to discuss proposed gender competency framework for cancer workforce
Nazik Hammad shared a post by Julie Gralow on X/Twitter, adding: ”Please join our session…
Apr 22, 2024, 19:44 | Insight
Ophira Ginsburg: Our new paper on sex and authorship in global cancer research, led by the amazing amazing Dr Miriam Mutebi
Ophira Ginsburg shared on LinkedIn: "Just out! Our new paper on sex and authorship in global…
Apr 20, 2024, 16:19 | Blog
Luis Martinez-Juarez: Dive deep into the profound gender inequalities permeating oncology and cancer care
Luis Martinez-Juarez, Affiliate at The Johns Hopkins Center for Humanitarian Health, shared a post on LinkedIn:…
Apr 20, 2024, 07:47 | Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 19, 2024, 08:03 | Blog
Ophira Ginsburg: Congratulations to all the authors of this important report
Ophira Ginsburg shared a post  by The Lancet, on LinkedIn: "Congratulations to all the authors of…
Apr 18, 2024, 15:06 | Blog
Many people with breast cancer are being ‘systematically left behind’ due to inaction on inequities and hidden suffering, says a new Lancet Commission - The Lancet
The Lancet shared a post on LinkedIn: "Many people with breast cancer are being ‘systematically left…
Apr 18, 2024, 11:13 | Insight
Luis Martinez-Juarez: Join us for an enlightening journey with Ophira Ginsburg, Co-Chair of The Lancet Commission on Women, Power, and Cancer, in our latest interview
Luis Martinez-Juarez, Senior Research and Programme Manager at the Carlos Slim Foundation, shared a post…
Apr 15, 2024, 01:19 | Blog
Prostate cancer cases are projected to double to 2.9 million per year by 2040 - The Lancet
The Lancet shared on X/Twitter: "Prostate cancer cases are projected to double to 2.9 million…
Apr 13, 2024, 07:34 | Blog
Erman Akkus: Commission on prostate cancer in The Lancet
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Commission on prostate…
Apr 12, 2024, 15:54 | Blog
Cynthia Villarreal-Garza: We are just weeks away from the launch of our new The Lancet Commission on breast cancer
Cynthia Villarreal-Garza, Medical Oncologist at Tecnológico de Monterrey, shared on their X/Twittter: ''After years of…
Apr 8, 2024, 16:54 | Blog
Antonio Passaro: The phase 3 KRYSTAL-12 trial represents a significant advancement in our understanding and treatment of KRAS-mutated NSCLC
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn: "Why…
Apr 8, 2024, 15:49 | Insight
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X: "The TRAIN3…
Apr 7, 2024, 11:58 | Drugs
Cathy Eng: Award for my contribution to The Lancet: FRESCO-2 and the FDA approval of fruquintinib
Cathy Eng shared on X/Twitter: "This lovely keepsake arrived. I want to thank Vanderbilt University Medical…
Apr 6, 2024, 07:14 | Drugs
Antonio Passaro: Why is this press release of Bristol Myers Squibb so crucial for our community?
Antonio Passaro, Medical Director at the Institute of European Oncology (IEO), shared a post on…
Apr 4, 2024, 14:05 | Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Mar 22, 2024, 18:40 | Insight
Michael Makris: Great results when governments and public health services work together
Michael Makris, Professor of Haemostasis and Thrombosis at University of Sheffield, shared on X/Twitter: "Amazing.…
12
All: 126 Posts: 1 - 100
Special Coverage